Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - Other
Ratios

Aclaris Therapeutics (ACRS) Leases (2019 - 2020)

Aclaris Therapeutics (ACRS) has 2 years of Leases data on record, last reported at $435000.0 in Q3 2020.

  • For Q3 2020, Leases changed 0.0% year-over-year to $435000.0; the TTM value through Sep 2020 reached $435000.0, changed 0.0%, while the annual FY2019 figure was $435000.0, N/A changed from the prior year.
  • Leases reached $435000.0 in Q3 2020 per ACRS's latest filing, roughly flat from $435000.0 in the prior quarter.
  • Across five years, Leases topped out at $2.6 million in Q1 2019 and bottomed at $435000.0 in Q3 2019.